KR0164464B1 - A process for preparing penicillanic acid derivatives - Google Patents

A process for preparing penicillanic acid derivatives Download PDF

Info

Publication number
KR0164464B1
KR0164464B1 KR1019960007195A KR19960007195A KR0164464B1 KR 0164464 B1 KR0164464 B1 KR 0164464B1 KR 1019960007195 A KR1019960007195 A KR 1019960007195A KR 19960007195 A KR19960007195 A KR 19960007195A KR 0164464 B1 KR0164464 B1 KR 0164464B1
Authority
KR
South Korea
Prior art keywords
samarium
compound
mmol
hydrogen
iodine
Prior art date
Application number
KR1019960007195A
Other languages
Korean (ko)
Other versions
KR970065540A (en
Inventor
조용서
고훈영
장문호
배애님
강한영
Original Assignee
김은영
한국과학기술원
정지석
한미약품공업주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김은영, 한국과학기술원, 정지석, 한미약품공업주식회사 filed Critical 김은영
Priority to KR1019960007195A priority Critical patent/KR0164464B1/en
Publication of KR970065540A publication Critical patent/KR970065540A/en
Application granted granted Critical
Publication of KR0164464B1 publication Critical patent/KR0164464B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/04Preparation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/865Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 6
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 테트라히드로퓨란 및 아세토니트릴 용매에서 일반식(I)의 화합물과 사마리움(II) 요오드를 0∼-78℃에서 반응시키는 것으로 이루어지는, 항균제, 항균제 저해제, 또는 이들의 중간체로 이용되는, 일반식(II) 화합물을 제조하는 방법에 관한 것이다.The present invention is used as an antimicrobial agent, an antimicrobial inhibitor, or an intermediate thereof, consisting of reacting a compound of formula (I) and samarium (II) iodine at 0 to -78 ° C in a tetrahydrofuran and acetonitrile solvent. It relates to a process for preparing the general formula (II) compound.

상기 식에서 X'와 X는 각각 할로겐 원소 또는 수소이고, X는 할로겐 원소 또는 수소이나 X'와 X가 모두 수소인 경우는 제외되며; n은 0, 1 또는 2이고; R은 수소, 알칼리 금속 양이온, 카르복실산염 형성기 또는 카르복시 보호기이다.Wherein X 'and X are each an elemental halogen or hydrogen, except that X is a halogen element or hydrogen or where both X' and X are hydrogen; n is 0, 1 or 2; R is hydrogen, an alkali metal cation, a carboxylate forming group or a carboxy protecting group.

Description

페니실란산 유도체의 제조방법Preparation method of peniclanic acid derivative

본 발명은 일반식(I)의 페니실란산 유도체를 탈할로겐화하는 것으로 이루어지는, 6위치에 한 개 또는 두 개의 할로겐을 가지는 일반식(II) 화합물을 합성하는 신규한 제조방법에 관한 것이다.The present invention relates to a novel process for synthesizing a compound of formula (II) having one or two halogens at the 6 position, which consists in dehalogenating a penicsilane acid derivative of formula (I).

상기 식에서 X'와 X는 각각 할로겐 원소 또는 수소이나 X'와 X가 모두 수소인 경우는 제외되며; n은 0, 1 또는 2이고; R은 수소, 알칼리 금속 양이온, 카르복실산염 형성기 또는 카르복시 보호기이다.Wherein X 'and X are each a halogen element or a hydrogen or X' and X are both hydrogen; n is 0, 1 or 2; R is hydrogen, an alkali metal cation, a carboxylate forming group or a carboxy protecting group.

상기 일반식(II) 화합물은 항균제의 저해제 또는 항균제 분해효소의 억제제의 제조를 제조하는데 중간체로 유용하며, 항균제 제조의 중간체로서 유용하다.The general formula (II) compounds are useful as intermediates for the preparation of inhibitors of antimicrobial agents or inhibitors of antimicrobial degrading enzymes, and are useful as intermediates for the preparation of antimicrobial agents.

상기 일반식(II) 화합물에서, X=H, n=2인 페니실란산 1,1-디옥사이드는 항균제 및 베타락탐 항생물질과 병용하여 항균 활성을 증진시키는데 유용한 것으로 알려져 있다.In the above general formula (II) compounds, peniclanic acid 1,1-dioxide of X = H, n = 2 is known to be useful for enhancing antimicrobial activity in combination with antibacterial and beta-lactam antibiotics.

또한 일반식(II)로 표시되는 그 밖의 페니실란산 유도체는 기타 항균제 또는 항균제 분해효소의 억제제의 제조를 제조하는데 중간체로 유용하다.In addition, other penicilanic acid derivatives represented by formula (II) are useful as intermediates for the preparation of other antimicrobial agents or inhibitors of antimicrobial degrading enzymes.

페니실린이나 세파로스포린과 같은 베타락탐 항생제에 특별한 저항력이 있는 내성균들은 대부분의 경우 베타락타마제라는 효소를 분비하여 베타락탐계 항생제인 베타락탐 구조를 가수분해시킴으로써 약효를 무력화시킨다고 알려져 있다.Resistant bacteria that are particularly resistant to beta-lactam antibiotics, such as penicillin and cephalosporin, are known to inactivate the drug by hydrolyzing the beta-lactam antibiotic beta-lactam structure in most cases by secreting an enzyme called beta-lactamase.

베타락타마제 활성을 억제하는 능력을 가지는 물질을 베타락마제 저해제(억제제)라고 하며, 이같은 저해제를 페니실린과 같은 항생제와 병행하여 사용하면 상승효과로 인해 저해제와 항생제 개개 성분의 항균 작용의 합보다 항균작용이 월등이 좋아지는 항균효과의 증진이 있다고 한다.Substances that have the ability to inhibit beta-lactamase activity are called beta-lactamase inhibitors (inhibitors). When these inhibitors are used in combination with antibiotics such as penicillin, they are more antibacterial than the sum of the antimicrobial effects of the individual inhibitors and antibiotics It is said that there is an improvement in antibacterial effect that the effect is better.

상기 일반식(II)로 표시되는 화합물 및 그의 염은 공지의 물질(Antimicrob. Agents Chemother, 21, 506(1978))로, 베타락타마제 저해제로 유용하며, 베타락타마제를 분비하는 내성균에 대한 베타락탐 항생제의 효과를 증진시키는 것으로 알려졌다.The compound represented by the general formula (II) and salts thereof are known substances (Antimicrob. Agents Chemother, 21, 506 (1978)), useful as inhibitors of beta lactamase, and beta to resistant bacteria that secrete beta lactamase. It is known to enhance the effects of lactam antibiotics.

탈할로겐화 방법에 의해 일반식(II) 화합물을 제조하는 방법으로 다음과 같은 방법이 알려져 있다. 미국특허 4,180,506호에서는 팔라듐/탄소 촉매를 사용하여 수소화반응으로 6,6-페니실린술폰산으로부터 모노-브로모페니실린술폰산을 합성하였으나 이 방법은 고압수소를 사용하여야 하는 단점이 있고, EP 0013617와 Tetrahedron 15, 2477(1983)은 트리알킬 및 트리알릴주석 수소화물을 이용하여 6,6-디브로모페니실린술폰산 및 그것의 에스테르 유도체로부터 6-브롬 이성질체를 얻었으나 이 반응은 고온(약 100℃)에서 용매를 환류시키면서 진행해야 하고, 출발물질과 6α-, 6β-모노브로모페니실린술폰산 화합물의 혼합물이 얻어지므로 분리의 어려움이 있다. EP 0092286와 EP 139282들은 각각 아연과 마그네슘을 이용하여 6,6-디브로모 페니실린 술폰산 및 그것의 에스테르 유도체를 탈브롬화시켰으나 반응 조건을 항상 pII가 2∼6 정도의 산성으로 유지하여야 한다. WO 87/06230에는 알킬 아인산염을 사용하여 탈브롬화하는 것이 기재되어 있다. 이 방법은 반응시간이 2∼4시간으로 길고, 아인산염의 유독성이라는 단점이 있다.The following method is known as a method of preparing general formula (II) compound by the dehalogenation method. In US Pat. No. 4,180,506, mono-bromophenicillin sulfonic acid was synthesized from 6,6-penicillin sulfonic acid by hydrogenation using a palladium / carbon catalyst, but this method has the disadvantage of using high pressure hydrogen, EP 0013617 and Tetrahedron 15, 2477 (1983) obtained 6-bromine isomers from 6,6-dibromophenicillinsulfonic acid and ester derivatives thereof using trialkyl and triallyl tin hydrides, but the reaction was carried out at high temperature (about 100 ° C.). It must proceed while refluxing, and since a mixture of the starting material and the 6α-, 6β-monobromophenicillin sulfonic acid compound is obtained, there is a difficulty in separation. EP 0092286 and EP 139282 debrominated 6,6-dibromo penicillin sulfonic acid and its ester derivatives with zinc and magnesium, respectively, but the reaction conditions should always be maintained at an acid with a pII of 2-6. WO 87/06230 describes debromination with alkyl phosphites. This method has a long reaction time of 2 to 4 hours and has the disadvantage of toxic phosphite.

본 발명은 테트라히드로퓨란 또는 아세토니트릴 용매에서 사마리움(II) 요오드와 일반식(1) 화합물을 사용하는 것으로 이루어지는 일반식(II) 화합물을 제조하는 방법에 관한 것이다.The present invention relates to a process for preparing a compound of formula (II) comprising the use of samarium (II) iodine and a compound of formula (1) in a tetrahydrofuran or acetonitrile solvent.

상기 식에서 X'와 X는 각각 할로겐 원소 또는 수소이나 X'와 X가 모두 수소인 경우는 제외되며; n은 0,1 또는 2이고; R은 수소, 알칼리 이온 양이온, 카르복실산염 형성기 또는 카르복시 보호기이다. 상기 R로 표시되는 알칼리 금속 양이온, 카르복실산염 형성기 또는 카르복시 보호기로 사용될 수 있는 원소 또는 기는 이 분야에서 잘 알려져 있으며, 예를 들면, 나트륨, 칼륨, 마그네슘 등의 알칼리 금속 양이온, 4-메톡시벤질, 4-니트로벤질, 디페닐메틸, 알릴, 삼차부틸, 알킬, 메톡시메틸, 메틸티오메틸, 메톡시에톡시메틸, 트리클로로에틸, 트리메틸실릴 등이 사용될 수 있으나 이들에 제한되지는 않는다.Wherein X 'and X are each a halogen element or a hydrogen or X' and X are both hydrogen; n is 0, 1 or 2; R is hydrogen, an alkali ion cation, a carboxylate forming group or a carboxy protecting group. Elements or groups that can be used as the alkali metal cation, carboxylate group or carboxy protecting group represented by R are well known in the art, for example, alkali metal cations such as sodium, potassium, magnesium, 4-methoxybenzyl , 4-nitrobenzyl, diphenylmethyl, allyl, tert-butyl, alkyl, methoxymethyl, methylthiomethyl, methoxyethoxymethyl, trichloroethyl, trimethylsilyl and the like can be used, but is not limited thereto.

사마리움은 란탄족 원소이며, 사마리움(II) 요오드는 테트라히드로퓨란이나 아세토니트릴 용매에서 사마리움 금속을 디요오드 메탄, 디요오드 에탄, 요오드 또는 수은(II) 요오드 등으로 처리하면 얻을 수 있다. 일반적으로 테트라히드로퓨란이나 아세토니트릴 용매에서 사마리움과 디요오드 메탄 혹은 디요오드 에탄을 상온에서 1∼2시간 교반하면 정량적으로 제조된다.Samarium is a lanthanide element, and samarium (II) iodine can be obtained by treating samarium metal with diiodine methane, diiodine ethane, iodine or mercury (II) iodine in a tetrahydrofuran or acetonitrile solvent. In general, it is quantitatively prepared by stirring samarium and diiodine methane or diiodine ethane at room temperature for 1 to 2 hours in a tetrahydrofuran or acetonitrile solvent.

J. Org, Chem., 51, 1135(1986); J. Org. Chem, 51, 2596(1986), Tetrahedron Lett., 28, 4437(1987)에, 사마리움(II) 요오드를 사용하여 케톤화합물의 α-위치를 탈할로겐화하는 것이 기술되어 있다.J. Org, Chem., 51, 1135 (1986); J. Org. Chem, 51, 2596 (1986), Tetrahedron Lett., 28, 4437 (1987) describe the dehalogenation of the α-position of ketone compounds using samarium (II) iodine.

본 발명의 제조방법은 상온∼-78℃에서 수행된다. 반응 온도가 높을수록 반응이 빠르게 진행되나, 반응수율이나 반응생성물의 순도를 고려할 때 -60℃∼-78℃가 바람직하다. 본 발명의 제조방법은 중성,산성 또는 염기성 조건하에서 수행될 수 있으므로, 사용 반응물 자체의 액성만으로 충분하다.The production method of the present invention is carried out at room temperature to -78 ℃. The higher the reaction temperature, the faster the reaction, but considering the reaction yield and the purity of the reaction product is preferably -60 ℃ to -78 ℃. Since the preparation method of the present invention can be carried out under neutral, acidic or basic conditions, the liquidity of the reactant itself used is sufficient.

반응 용매로는 테트라히드로퓨란 또는 아세토니트릴 등이 사용될 수 있다.Tetrahydrofuran or acetonitrile may be used as the reaction solvent.

사마리움(II) 요오드는 일반식(I) 화합물에 대해 몰비로 2.0∼4.0배를 사용할 수 있지만 약 2.5∼3.8배를 사용하는 것이 바람직하다.Samarium (II) iodine may be used in a molar ratio of 2.0 to 4.0 times with respect to the general formula (I) compound, but it is preferable to use about 2.5 to 3.8 times.

추가로 헥사메틸포스포라미드를 첨가하면 수율과 반응 속도 면에서 바람직하며 사용량은 용매에 대해 0%∼20%이나, 5%∼10%가 바람직하다.The addition of hexamethylphosphoramide is preferable in terms of yield and reaction rate, and the amount of use is preferably 0% to 20% with respect to the solvent, but preferably 5% to 10%.

여분의 사마리움(II) 요오드는 포화 암모니아수를 가하여 분해시킬 수 있으며, 반응혼합물을 유기용매로 추출하고, 증발 건조하여 일반식(II) 화합물을 얻는다.The extra samarium (II) iodine can be decomposed by adding saturated ammonia water, and the reaction mixture is extracted with an organic solvent and evaporated to dryness to obtain a compound of formula (II).

사마리움(II) 요오드를 사용한 본 발명은 방법은 저온에서 수분 이내에 반응이 완결되며, 정량적으로 고 순도의 목적화합물을 얻을 수 있고, 반응이 깨끗하고 안전하고 분리가 용이하다. 또한 출발물질인 일반식(I) 화합물이 디할로겐 화합물인 경우, 반응 시간을 조절함에 의해 입체 이성질체인 모노 α-할로겐 화합물만 순수하게 얻거나, 할로겐이 모두 제거된 페니실란산 유도체를 얻을 수 있다는 장점이 있다. 모노 α-할로겐 화합물은 기타 항균제 분해효소의 억제제를 제조하기 위한 중간체로 사용될 수 있다.In the present invention using samarium (II) iodine, the reaction is completed within a few minutes at low temperature, and the target compound can be obtained quantitatively with high purity, and the reaction is clean, safe and easy to separate. In addition, when the general formula (I) compound as the starting material is a dihalogen compound, only the mono α-halogen compound, which is a stereoisomer, can be obtained purely or a penicilanic acid derivative in which all halogens are removed by controlling the reaction time. There is an advantage. Mono α-halogen compounds can be used as intermediates for preparing inhibitors of other antimicrobial degrading enzymes.

다음의 실시예들은 본 발명의 방법을 보다 상세히 설명해 줄 것이나, 실시예들에 의해 본 발명의 범위가 제한되지는 않는다.The following examples will illustrate the method of the present invention in more detail, but the scope of the present invention is not limited by the examples.

핵자기 공명스펙트라(300MIIz)는 피이크 형태에 따라 다음의 약자를 사용한다; s:단일선, d:이중선, t:3중선, q:4중선Nuclear magnetic resonance spectra (300MIIz) use the following abbreviations, depending on the shape of the peak; s: single line, d: double line, t: triplet, q: quadruple

[실시예 1]Example 1

6α-브로모 페니실란산 디페닐메틸 에스테르 1,1-디옥시드의 제조Preparation of 6α-bromo peniclanic acid diphenylmethyl ester 1,1-dioxide

A:A:

질소 대기하에서 6,6-디브로모 페니실란산 디페닐메틸 에스테르 1,1-디옥시드 200mg(0.36mmol)을 테트라히드로퓨란 5ml에 녹이고 -78℃로 냉각시킨 후 헥사메틸포스포라미드(8.6v/v%)를 포함하고 있는 사마리움 디요오드(0.16M) 용액 5.5ml(0.90mmol)을 천천히 가하여 10분간 반응시켰다. 반응용기에 포화 암모니아수를 가한 후 에탈 아세테이트 20ml를 가하고 물과 소금물로 씻었다. 유기층을 무수 마그네슘설페이트로 건조, 감압증류하여 목적 화합물 170mg(0.36mmol, 100%)을 얻었다.In a nitrogen atmosphere, 200 mg (0.36 mmol) of 6,6-dibromo peniclanic acid diphenylmethyl ester 1,1-dioxide was dissolved in 5 ml of tetrahydrofuran and cooled to -78 ° C, followed by hexamethylphosphoramide (8.6 v). / v%) containing 5.5 ml (0.90 mmol) of samarium diiodine (0.16 M) solution was slowly added to react for 10 minutes. Saturated ammonia water was added to the reaction vessel, 20 ml of ethanol was added thereto, and the mixture was washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and distilled under reduced pressure to obtain 170 mg (0.36 mmol, 100%) of the title compound.

B:B:

질소 대기하에서 6,6-디브로모 페니실란산 디페닐메틸 에스테르 1,1-디옥시드 20mg(0.36mmol)을 테트라히드로퓨란 5ml에 녹이고 상온에서 사마리움 디요오드 용액 5.5ml(0,80mmol)을 천천히 가하면 약 5분 이내에 반응이 완결되었다. 반응용기에 포화 암모니아수를 가한 후 에틸 아세테이트 20ml를 가하고 물과 소금물로 씻었다. 유기층을 무수 마그네슘설페이트로 건조, 감압증류하여 목적 화합물 162ml(0.36mmol, 95%)을 얻었다.In a nitrogen atmosphere, 20 mg (0.36 mmol) of 6,6-dibromo peniclanic acid diphenylmethyl ester 1,1-dioxide was dissolved in 5 ml of tetrahydrofuran, and 5.5 ml (0,80 mmol) of samarium diiodine solution was added at room temperature. When added slowly, the reaction was completed within about 5 minutes. Saturated ammonia water was added to the reaction vessel, and 20 ml of ethyl acetate was added thereto and washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and distilled under reduced pressure to obtain 162 ml (0.36 mmol, 95%) of the title compound.

[실시예 2]Example 2

6α-디브로모 페니실란산 디페닐메틸 에스테르 제조Preparation of 6α-dibromo peniclanic acid diphenylmethyl ester

A:A:

질소 대기하에서 6,6-디브로모 페니실란산 디페닐메틸 에스테르 200mg(0.38mmol)을 테트라히드로퓨란 5ml에 녹이고 -78℃로 냉각시킨 후 헥사메틸포스포라미드(8.6v/v%)를 포함하는 사마리움 디요오드(0.16M) 용액 7.5ml(1.23mmol)을 천천히 가하면 10분 정도 이내에 반응이 완결되었다. 반응 용기에 포화 암모니아수를 가한 후 에틸 아세테이트 20ml를 가하고 물과 소금물로 씻었다. 유기층을 무수 마그네슘설페이트로 건조, 감압증류하여 목적 화합물 169mg(0.38mmol, 100%)을 얻었다.In a nitrogen atmosphere, 200 mg (0.38 mmol) of 6,6-dibromo peniclanic acid diphenylmethyl ester was dissolved in 5 ml of tetrahydrofuran and cooled to -78 ° C, followed by hexamethylphosphoramide (8.6 v / v%). After slowly adding 7.5 ml (1.23 mmol) of samarium diiodine (0.16 M) solution, the reaction was completed within about 10 minutes. Saturated ammonia water was added to the reaction vessel, and 20 ml of ethyl acetate was added thereto and washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and distilled under reduced pressure to obtain 169 mg (0.38 mmol, 100%) of the title compound.

B:B:

질소 대기하에서 6,6-디브로모 페니실란산 디페닐메틸 에스테르 200mg(0.38mmol)을 테트라히드로퓨란 5ml에 녹이고 0℃로 냉각시킨 후 사마리움 디요오드 용액(1.87mmol)을 천천히 가하면 10분 정도 이내에 반응이 완결되었다. 반응 용기에 포화 암모니아수를 가한 후 에틸 아세테이트 20ml를 가하고 물과 소금물로 씻었다. 유기층을 무수 마그네슘설페이트로 건조, 감압증류하여 목적 화합물 160mg(0.36mmol, 95%)을 얻었다.Under nitrogen atmosphere, 200 mg (0.38 mmol) of 6,6-dibromo peniclanic acid diphenylmethyl ester was dissolved in 5 ml of tetrahydrofuran, cooled to 0 ° C., and then slowly added to samarium diiodine solution (1.87 mmol) for about 10 minutes. The reaction was complete within a while. Saturated ammonia water was added to the reaction vessel, and 20 ml of ethyl acetate was added thereto and washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and distilled under reduced pressure to obtain 160 mg (0.36 mmol, 95%) of the title compound.

[실시예 3]Example 3

6α-브르모 페니실란산 디페닐메틸 에스테르 1-옥시드 제조Preparation of 6α-Bromophenic Acid Diphenylmethyl Ester 1-oxide

A:A:

질소 대기하에서 6,6-디브로모 페니실란산 디페닐메틸 에스테르 1-옥시드 200mg(0.37mmol)을 테트라히드로퓨한 3ml에 녹이고 -78℃로 냉각시킨 후 헥사메틸포스포라미드(8.6v/v%)를 포함하고 있는 사마리움 디요오드(0.16M) 용액 7.5ml(1.23mmol)을 천천히 가하여 10분 정도 반응시켰다. 반응용기에 포화 암모니아수를 가한 후 에틸 아세테이트 20ml를 가하고 물과 소금물로 씻었다. 유기층을 무수 마그네슘설페이트로 건조, 감압증류하여 목적 화합물 150mg(0.33mmol, 88%)을 얻었다.In a nitrogen atmosphere, 200 mg (0.37 mmol) of 6,6-dibromo peniclanic acid diphenylmethyl ester 1-oxide was dissolved in 3 ml of tetrahydrofuran, cooled to -78 ° C, and then hexamethylphosphoramide (8.6 v / 7.5 ml (1.23 mmol) of samarium diiodine (0.16 M) solution containing v%) was slowly added to react for 10 minutes. Saturated ammonia water was added to the reaction vessel, and 20 ml of ethyl acetate was added thereto and washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and distilled under reduced pressure to obtain 150 mg (0.33 mmol, 88%) of the title compound.

B:B:

질소 대기하에서 6,6-디브로모 페니실란산 디페닐메틸 에스테르 1-옥시드 200mg(0.37mmol)을 테트라히드로퓨란 3ml에 녹이고 상온에서 사마리움 디요오드(0.16M) 용액(1.87mmol)을 천천히 가하여 10분 정도 반응시켰다. 반응용기에 포화 암모니아수를 가한 후 에틸 아세테이트 20ml를 가하고 물과 소금물로 씻었다. 유기층을 무수 마그네슘설페이트로 건조, 감압증류하여 목적 화합물 137mg(0.30mmol, 80%)을 얻었다.In a nitrogen atmosphere, 200 mg (0.37 mmol) of 6,6-dibromo peniclanic acid diphenylmethyl ester 1-oxide was dissolved in 3 ml of tetrahydrofuran, and a samarium diiodine (0.16 M) solution (1.87 mmol) was slowly added at room temperature. The reaction was added for 10 minutes. Saturated ammonia water was added to the reaction vessel, and 20 ml of ethyl acetate was added thereto and washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and distilled under reduced pressure to obtain 137 mg (0.30 mmol, 80%) of the title compound.

[실시예 4]Example 4

6α-요오도 페니실란산 디페닐메틸 에스테르 1,1-디옥시드의 제조Preparation of 6α-iodo peniclanic acid diphenylmethyl ester 1,1-dioxide

6,6-디요오도 페니실란산 디페닐메틸 에스테르 1,1-디옥시드 236mg(0.36mmol)을 사용하는 것을 제외하고는 실시예 1A와 동일한 방법으로 실시하여 목적화합물을 수율 97%로 얻었다.Except for using 236 mg (0.36 mmol) of 6,6-diiodophenylanic acid diphenylmethyl ester 1,1-dioxide, the target compound was obtained in 97% yield.

[실시예 5]Example 5

6α-요오도 페니실란산 디페닐메틸 에스테르 제조Preparation of 6α-iodo Peniclanic Acid Diphenylmethyl Ester

6,6-디요오도 페니실란산 디페닐메틸 에스테르 237mg(0.38mmol)을 사용하는 것을 제외하고는 실시예 2A와 동일한 방법으로 실시하여 목적화합물을 수율 98%로 얻었다.A target compound was obtained in a yield of 98% by the same method as Example 2A, except that 237 mg (0.38 mmol) of 6,6-diiodophenylanic acid diphenylmethyl ester was used.

[실시예 6]Example 6

6α-요오도 페니실란산 디페닐메틸 에스테르 1-옥시드 제조Preparation of 6α-iodo peniclanic acid diphenylmethyl ester 1-oxide

6,6-디요오도 페니실란산 디페닐메틸 에스테르 1-옥시드 236mg(0.37mmol)을 사용하는 것을 제외하고는 실시예 3A와 동일한 방법으로 실시하여 목적화합물을 수율 99%로 얻었다.A target compound was obtained in a yield of 99% by the same method as Example 3A, except that 236 mg (0.37 mmol) of 6,6-diiodophenylanic acid diphenylmethyl ester 1-oxide was used.

[실시예 7]Example 7

페니실란산 디페닐메틸 에스테르 1,1-디옥시드의 제조Preparation of Peniclanic Acid Diphenylmethyl Ester 1,1-Dioxide

질소 대기하에서 6α-브로모(또는 -요오드, -클로로) 페니실란산 디페닐메틸 에스테르 1,1-디옥시드 150mg(0.31mmol)을 테트라히드로퓨란 4ml에 녹이고 -78℃로 냉각시킨 후 헥사메틸포스포라미드(8.6v/v%)를 포함하고 있는 사마리움 디요오드(0.16M) 용액 4.0ml(0.65mmol)을 천천히 가하여 10분 정도 반응시켰다. 반응용기에 포화 암모니아수를 가한 후 에틸 아세테이트 20ml를 가하고 물과 소금물로 씻었다. 유기층을 무수 마그네슘설페이트로 건조, 감압증류하여 목적 화합물 105mg(0.29mmol, 92%)을 얻었다.In a nitrogen atmosphere, 150 mg (0.31 mmol) of 6α-bromo (or -iodine, -chloro) peniclanic acid diphenylmethyl ester 1,1-dioxide was dissolved in 4 ml of tetrahydrofuran, cooled to -78 ° C, and then hexamethylphosphate. 4.0 ml (0.65 mmol) of samarium diiodine (0.16 M) solution containing poramide (8.6 v / v%) was slowly added to react for 10 minutes. Saturated ammonia water was added to the reaction vessel, and 20 ml of ethyl acetate was added thereto and washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and distilled under reduced pressure to obtain 105 mg (0.29 mmol, 92%) of the title compound.

[실시예 8]Example 8

페니실란산 디페닐메틸 에스테르 제조Peniclanic Acid Diphenylmethyl Ester Preparation

질소 대기하에서 6-브로모(또는 요오드, 클로로-) 페니실란산 디페닐메틸 에스테르 150mg(0.34mmol)을 테트라히드로퓨란 5ml에 녹이고 -78℃로 냉각시킨 후 헥사메틸포스포라미드(8.6v/v%)를 포함하고 있는 사마리움 디요오드(0.16M) 용액 5.2ml(0.85mmol)을 천천히 가하여 10분 정도 반응시켰다. 반응용기에 포화 암모니아수를 가한 후 에틸 아세테이트 20ml를 가하고 물과 소금물로 씻었다. 유기층을 무수 마그네슘설페이트로 건조, 감압증류하여 목적 화합물 113mg(0.31mmol, 90%)을 얻었다.In a nitrogen atmosphere, 150 mg (0.34 mmol) of 6-bromo (or iodine, chloro-) peniclanic acid diphenylmethyl ester was dissolved in 5 ml of tetrahydrofuran and cooled to -78 ° C, followed by hexamethylphosphoramide (8.6 v / v). 5.2 ml (0.85 mmol) of samarium diiodine (0.16 M) solution containing%) was slowly added to react for 10 minutes. Saturated ammonia water was added to the reaction vessel, and 20 ml of ethyl acetate was added thereto and washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and distilled under reduced pressure to obtain 113 mg (0.31 mmol, 90%) of the title compound.

[실시예 9]Example 9

페니실란산 디페닐메틸 에스테르 1-옥시드 제조Peniclanic Acid Diphenylmethyl Ester 1-oxide Preparation

질소 대기하에서 6-브로모(또는 요오드, 클로로-) 페니실란산 디페닐메틸 에스테르 1-옥시드 150mg(0.33mmol)을 테트라히드로퓨란 5ml에 녹이고 -78℃로 냉각시킨 후 헥사메틸포스포라미드(8.6v/v%)를 포함하는 사마리움 디요오드(0.16M) 용액 5.2ml(0.85mmol)을 천펀히 가하여 10분 정도 반응시켰다. 반응용기에 포화 암모니아수를 가한 후 에틸 아세테이트 20ml를 가하고 물과 소금물로 씻었다. 유기층을 무수 마그네슘설페이트로 건조, 감압증류하여 목적 화합물 113mg(0.30mmol, 90%)을 얻었다.In a nitrogen atmosphere, 150 mg (0.33 mmol) of 6-bromo (or iodine, chloro-) peniclanic acid diphenylmethyl ester 1-oxide was dissolved in 5 ml of tetrahydrofuran and cooled to -78 ° C, followed by hexamethylphosphoramide ( 5.2 ml (0.85 mmol) of samarium diiodine (0.16 M) solution containing 8.6 v / v%) was added slowly and reacted for 10 minutes. Saturated ammonia water was added to the reaction vessel, and 20 ml of ethyl acetate was added thereto and washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and distilled under reduced pressure to obtain 113 mg (0.30 mmol, 90%) of the title compound.

Claims (4)

테트라히드로퓨란 또는 아세토니트릴 용매에서 일반식(I)의 화합물과 사마리움(II) 요오드를 0∼-78℃에서 반응시키는 것으로 이루어지는 일반식(II) 화합물을 제조하는 방법A process for preparing the compound of formula (II) comprising the reaction of a compound of formula (I) with samarium (II) iodine at 0-78 ° C. in a tetrahydrofuran or acetonitrile solvent 상기 식에서 X'와 X는 각각 할로겐 원소 또는 수소이나 X'와 X가 모두 수소인 경우는 제외되며; n은 0, 1 또는 2이고; R은 수소, 알칼리 금속 양이온, 카르복실산염 형성기 또는 카르복시 보호기이다.Wherein X 'and X are each a halogen element or a hydrogen or X' and X are both hydrogen; n is 0, 1 or 2; R is hydrogen, an alkali metal cation, a carboxylate forming group or a carboxy protecting group. 제1항에 있어서, 추가로 헥사메틸포스포라미드를 상기 용매에 대해 무게비로 20% 이하로 첨가하는 방법.The method of claim 1, further wherein hexamethylphosphoramide is added at 20% or less by weight relative to the solvent. 제1항에 있어서, 상기 일반식(I)의 화합물과 사마리움(II) 요오드를 몰비로 1:2∼1:4로 반응시키는 방법.The method according to claim 1, wherein the compound of formula (I) and samarium (II) iodine are reacted in a molar ratio of 1: 2 to 1: 4. 제1항에 있어서, 일반식(I)의 화합물과 사마리움(II) 요오드를 반응시킨 후 추가로 포화 암모니아수를 가하여 여분의 사마리움(II) 요오드를 분해시키는 것으로 이루어지는 방법.The method according to claim 1, wherein the compound of formula (I) is reacted with samarium (II) iodine, followed by further addition of saturated ammonia water to decompose the extra samarium (II) iodine.
KR1019960007195A 1996-03-18 1996-03-18 A process for preparing penicillanic acid derivatives KR0164464B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019960007195A KR0164464B1 (en) 1996-03-18 1996-03-18 A process for preparing penicillanic acid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019960007195A KR0164464B1 (en) 1996-03-18 1996-03-18 A process for preparing penicillanic acid derivatives

Publications (2)

Publication Number Publication Date
KR970065540A KR970065540A (en) 1997-10-13
KR0164464B1 true KR0164464B1 (en) 1999-01-15

Family

ID=19453296

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960007195A KR0164464B1 (en) 1996-03-18 1996-03-18 A process for preparing penicillanic acid derivatives

Country Status (1)

Country Link
KR (1) KR0164464B1 (en)

Also Published As

Publication number Publication date
KR970065540A (en) 1997-10-13

Similar Documents

Publication Publication Date Title
USRE34960E (en) Carbapenem compounds, and compositions containing them
US4526718A (en) 3,3-Di(acylthio)-2(4-allylthioazetidin-2-on-1-yl)propenoic acid ester compounds
PL129534B1 (en) Process for preparing novel derivatives of 6-beta-hydroxyalkylpenicillanic acid
DE2837264A1 (en) 7 BETA -ARYLMALONAMIDO-7 ALPHA -METHOXY-3-THIADIAZOLYLTHIO-1-OXADETHIACEPHALOSPORINE, THEIR ESTERS AND SALTS, AND METHOD FOR THE PRODUCTION THEREOF
EP0199446A1 (en) Penem compounds, production and use thereof
EP0076621B1 (en) Azetidinone derivatives
JPS61275279A (en) Carbapenem compound
JPH0342277B2 (en)
KR0164464B1 (en) A process for preparing penicillanic acid derivatives
US4374144A (en) β-Lactam compounds, their preparation and use
DK171842B1 (en) Penem derivatives, processes for their preparation and antibacterial agents containing them
HU194892B (en) Process for producing new peneme derivatives
HU192819B (en) Process for preparing antibacterial penemic derivatives
IE47037B1 (en) Isopenicillins, processes for their preparation, and compositions containing them
EP0031509B1 (en) Penem derivatives
PL125197B1 (en) Process for preparing 1,1-dioxide of penicillanic acid and its esters
HU194890B (en) Process for preparing 7-oxo-4-thia-1-azabicyclo /3.20/-hept-2-ene-derivatives of anti-microbial effect and for preparing pharmaceutical compositions containing such compounds
KR910009290B1 (en) Process for preparation of fluoralkylated carbapenene derivatives
CH624390A5 (en) Process for preparing alpha-ketocarboxylic acid compounds
US5506225A (en) Antibacterial penem compounds
GB2105329A (en) Penem-3-carboxylic acid derivatives their preparation and their use as antimicrobial agents
US4540580A (en) 2-[(1'R)-1'-Aminoalkyl]penems
KR870000313B1 (en) Process for preparing 6-(aminomethyl)penicillanic acid 1,1-dioxide and derivatives
NO833415L (en) PROCEDURE FOR PREPARING 6-AMINOALKYLPENICILLANIC ACID-1,1-DIOXYDES
KR100229817B1 (en) Phenem derivative and process for the preparation thereof

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20060313

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee